GENOPTIX
As a pioneering force in oncology, Genoptix regularly participates in industry conferences to share their findings, discuss emerging solutions, and create meaningful connections to advance the community.
GENOPTIX
Industry:
Communities Health Care Health Diagnostics Hospital
Founded:
1999-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.genoptix.com
Total Employee:
501+
Status:
Active
Contact:
(760)268-6200
Email Addresses:
[email protected]
Total Funding:
27.99 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 Person Schema Gravatar Profiles Amazon Route 53 IIS 10 DMARC ASP.NET 4.0 Fastly Hosted
Similar Organizations
Impact Lab
International company that provides highly specialized diagnostic services
Krsnaa Diagnostics
Krsnaa Diagnostics provides healthcare diagnostics services.
Liquid Biotech
Liquid Biotech is a technology for cancer diagnostics and gene discover
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-12-15 | Rosetta Genomics | Rosetta Genomics acquired by Genoptix | 10 M USD |
| 2012-09-01 | HistoRx | HistoRx acquired by Genoptix | N/A |
Investors List
Enterprise Partners
Enterprise Partners investment in Series C - Genoptix
Alliance Technology Ventures
Alliance Technology Ventures investment in Series C - Genoptix
Excelsior Venture Partners III
Excelsior Venture Partners III investment in Series C - Genoptix
Enterprise Partners
Enterprise Partners investment in Series B - Genoptix
Excelsior Venture Partners III
Excelsior Venture Partners III investment in Series B - Genoptix
Alliance Technology Ventures
Alliance Technology Ventures investment in Series B - Genoptix
Official Site Inspections
http://www.genoptix.com
- Host name: 23.185.0.2
- IP address: 23.185.0.2
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Genoptix"
Genoptix, Inc. - LinkedIn
Genoptix, Inc. | 8,236 followers on LinkedIn. Right Answer, Right Now | Genoptix, a NeoGenomics Company Right Answer, Right Now Advancing positive outcomes in oncology through …See details»
NeoGenomics Completes Acquisition of Genoptix, Inc.
MYERS, Fla., Dec. 10, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has …See details»
Genoptix Company Profile 2024: Valuation, Investors ... - PitchBook
Genoptix General Information Description. Provider of laboratory services intended to offer delivery of diagnostic and informatics services. The company offers in cancer-focused genetic …See details»
Genoptix - Products, Competitors, Financials, Employees, …
Genoptix. Frequently Asked Questions (FAQ) When was Genoptix founded? Genoptix was founded in 1999. Where is Genoptix's headquarters? Genoptix's headquarters is located at …See details»
NeoGenomics to Acquire Genoptix for $140M in Cash and Stock
Oct 23, 2018 NeoGenomics Laboratories said today it has agreed to acquire the clinical oncology laboratory Genoptix for about $140 million cash and stock combined, in a deal …See details»
Genoptix Company Profile - Office Locations, Competitors ... - Craft
Genoptix Summary. Company Summary. Overview. Genoptix is a company operating as a specialty oncology laboratory. It provides community and hospital physicians with testing …See details»
Genoptix - Funding, Financials, Valuation & Investors - Crunchbase
Genoptix is registered under the ticker NASDAQ:GXDX . Their stock opened with $17.00 in its Oct 30, 2007 IPO. Genoptix is funded by 4 investors. Hudson River Capital Partners and …See details»
NeoGenomics Completes Acquisition of Genoptix, Inc.
Oct 12, 2018 Genoptix is expected to contribute $85 million of revenue and break-even EBITDA in year one, $25 million of cost synergies over time, and 25% EBITDA margin by the end of …See details»
NeoGenomics to acquire Genoptix in near $140M deal
Oct 26, 2018 NeoGenomics has moved to acquire clinical oncology laboratory Genoptix for $125 million in cash plus 1 million shares of stock currently worth over $14 million.See details»
Novartis announces agreement to acquire Genoptix, Inc. in all cash ...
Jan 24, 2011 The Genoptix Board of Directors has unanimously approved the transaction and agreed to recommend that Genoptix stockholders tender their shares. The transaction is …See details»
NeoGenomics to acquire oncology laboratory Genoptix for $125m
Cancer-focused genetic testing services provider NeoGenomics has signed a definitive agreement to acquire US-based clinical oncology laboratory Genoptix in a $125m deal. The …See details»
Genoptix - Contacts, Employees, Board Members, Advisors & Alumni
Genoptix has 3 current employee profiles, including Co-Founder Sadik Esener. Contacts. Edit Contacts Section. Job Department. Protected Content. Sr VP, CTO. Non-Management, …See details»
NeoGenomics to Acquire Genoptix for Cash, Stock - GenomeWeb
Oct 23, 2018 Genoptix customers will be able to leverage NeoGenomics' comprehensive testing menu, broad portfolio of managed care and group purchasing organization contracts, and …See details»
NeoGenomics, Genoptix Deal Highlights Role of Community …
Nov 28, 2018 The Genoptix lab operations are located solely in Carlsbad, California, approximately 40 minutes south of a large NeoGenomics lab facility in Aliso Viejo, California. …See details»
Novartis Completes Sale of Genoptix Lab Business - GenomeWeb
Mar 7, 2017 In January, Ampersand and 1315 announced that they had partnered with a management group led by former Prometheus Laboratories CEO Joseph Limber to buy …See details»
NeoGenomics Signs Definitive Agreement to Acquire Genoptix
FT. MYERS, Fla., Oct. 23, 2018 (GLOBE NEWSWIRE) -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, announced today that it has …See details»
NeoGenomics Q4 Revenues Rise 25 Percent Bolstered by Genoptix ...
Feb 19, 2019 Genoptix also has an excellent molecular lab, and molecular leaders at Genoptix are now part of the current molecular leadership for the combined company, he noted. During …See details»
Genoptix, Bionano to Partner on Blood Cancer Diagnostics
Jun 28, 2017 Genoptix will use Bionano's Saphyr genome mapping solution to develop diagnostics for selected hematologic oncology indications in the U.S. …See details»
Genoptic - Crunchbase Company Profile & Funding
Genoptic is a research and development firm specializing in nano-optoelectronics, provides premium indoor and outdoor LED signs.See details»